89bio, Inc. (ETNB)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

535 MISSION STREET SAN FRANCISCO, CA 94105

89Bio, Inc. operates as a biopharmaceutical company. The Company develops treatments for liver and metabolic disorders. 89Bio serves customers in the State of California.

View SEC Filings from ETNB instead.

View recent insider trading info

Funds Holding ETNB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ETNB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DIROCCO DEREK

  • Director
0 2020-04-05 2

NASCHITZ ANAT

  • Director
  • 10% Owner
0 2020-04-05 3

HAYDEN MICHAEL R

  • Director
0 2020-04-05 3

GRUNBERG GREGORY

  • Director
  • 10% Owner
0 2020-04-05 3

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
3,825,008 2020-04-01 2

ALTSCHULER STEVEN

  • Director
24,083 2020-03-30 2

LE-NGUYEN QUOC SEE REMARKS

  • Officer
0 2020-02-14 2

MANSBACH HARRY H CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-14 2

WAISBOURD RAM COO AND CHIEF BUSINESS OFFICER

  • Officer
0 2020-02-14 2

MARTINS RYAN CHIEF FINANCIAL OFFICER

  • Officer
0 2020-02-14 2

PALEKAR ROHAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-02-14 2

LONGITUDE CAPITAL PARTNERS III, LLC

LONGITUDE VENTURE PARTNERS III, L.P.

TAMMENOMS BAKKER JULIET

ENRIGHT PATRICK G

  • 10% Owner
1,477,320 2020-01-29 2

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ORBIMED ADVISORS ISRAEL II LTD

ORBIMED ISRAEL GP II, L.P.

  • Director
  • 10% Owner
4,728,805 2019-11-11 2

KARIV TOMER

PONTIFAX (ISRAEL) V, L.P.

PONTIFAX (CAYMAN) V, L.P.

PONTIFAX (CHINA) V, L.P.

PONTIFAX 5 G.P. L.P.

PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.

PONTIFAX LATE STAGE GP LTD.

PONTIFAX LATE STAGE FUND L.P.

  • Director
  • 10% Owner
1,134,671 2019-11-11 2

KARIV TOMER

PONTIFAX (ISRAEL) V, L.P.

PONTIFAX (CAYMAN) V, L.P.

PONTIFAX (CHINA) V, L.P.

PONTIFAX 5 G.P. L.P.

PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.

  • Director
  • 10% Owner
0 2019-11-08 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HAYDEN MICHAEL R - Director

2020-04-05 A 7,000 a 7,000 0.00 direct

GRUNBERG GREGORY - Director - > 10% Owner

2020-04-05 A 7,000 a 7,000 0.00 direct

DIROCCO DEREK - Director

2020-04-05 A 7,000 a 7,000 0.00 direct

NASCHITZ ANAT - Director - > 10% Owner

2020-04-05 A 7,000 a 7,000 0.00 direct

ALTSCHULER STEVEN - Director

2020-03-23 A 40,000 a 40,000 0.00 direct

MARTINS RYAN - Officer CHIEF FINANCIAL OFFICER

2020-02-14 A 47,500 a 47,500 0.00 direct

MANSBACH HARRY H - Officer CHIEF MEDICAL OFFICER

2020-02-14 A 45,000 a 45,000 0.00 direct

WAISBOURD RAM - Officer COO AND CHIEF BUSINESS OFFICER

2020-02-14 A 30,000 a 30,000 0.00 direct

LE-NGUYEN QUOC - Officer SEE REMARKS

2020-02-14 A 50,000 a 50,000 0.00 direct

PALEKAR ROHAN - Director - Officer CHIEF EXECUTIVE OFFICER

2020-02-14 A 170,000 a 170,000 0.00 direct

Elevate your investments